Tadalafil Tablet, Film Coated
Product Images NDC 29300-289

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 29300-289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 01

Chemical structure of tadalafil, shown as a two-dimensional molecular diagram illustrating its atomic and bond arrangement.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 02

Four line graphs showing the differences in blood pressure measurements (standing systolic, standing diastolic, supine systolic, supine diastolic) over time in hours comparing tadalafil to placebo. Each graph plots the change in mmHg from 0 to 96 hours, with error bars indicating variability at each time point.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 03

Two line graphs showing systolic blood pressure changes over 24 hours post-dose, comparing tadalafil 20 mg with doxazosin 8 mg versus placebo with doxazosin 8 mg. The top graph depicts standing systolic blood pressure, and the bottom shows supine systolic blood pressure, both measured in mmHg over time in hours.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 04

A line graph illustrating the changes in systolic blood pressure (mmHg) over 12 hours following administration of tadalafil 20 mg or placebo combined with 8 mg once-daily doxazosin. The x-axis represents time after administration in hours, and the y-axis shows systolic blood pressure changes. Four data series compare measurements at 08:00 and 20:00 dosing times for both tadalafil and placebo groups.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 05

A pharmacokinetic curve showing plasma tadalafil concentration (µg/L) over time (hours) for different doses: single 20 mg dose, single 5 mg dose, and once-daily 5 mg dose following 5 consecutive days. The graph includes data points with error bars to indicate variability.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 06

A line graph comparing the change from baseline in IPSS Total Score over 12 weeks of treatment between Tadalafil 5 mg and placebo groups. The x-axis represents Duration of Treatment in weeks (0, 4, 8, 12) and the y-axis shows Change from Baseline in IPSS Total Score, with Tadalafil 5 mg showing a greater decrease compared to placebo. Statistical significance is noted at p<0.01.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 07

A line graph comparing change from baseline in IPSS total score over 12 weeks between tadalafil 5 mg and placebo. The x-axis represents duration of treatment in weeks, and the y-axis shows change from baseline. Tadalafil 5 mg shows a greater decrease in IPSS score compared to placebo over time, with statistical significance indicated at some points.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 08

A line graph showing the least-squares mean change from baseline over 26 weeks of therapy comparing Tadalafil/Finasteride and Placebo/Finasteride groups. The x-axis represents weeks of therapy (0, 4, 12, 26), and the y-axis shows mean change values from 0 to -7. Data points with statistical significance indicators are included.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 09

A line graph showing the change in I-PSS total score from baseline over 12 weeks comparing tadalafil 5 mg and placebo. The x-axis represents duration of treatment in weeks; the y-axis shows change from baseline in score. Two lines depict greater reduction in score with tadalafil 5 mg versus placebo over time, with statistical significance noted (p<0.01).*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 10

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 11

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 12

Packaging label for Tadalafil Tablets USP 2.5 mg film-coated tablets, for once daily use. The label shows storage instructions, usual dosage, manufacturer information (Unichem Laboratories Ltd.), and the labeling company (Unichem Pharmaceuticals USA, Inc.). The box contains 30 tablets (2 cards of 15 tablets each). Additional details on proper use and warnings are included on the label.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 13

Packaging label for Tadalafil Tablets USP 5 mg oral film-coated tablets. The label includes dosage instructions for once daily use, storage conditions, and warnings to keep out of reach of children. Manufactured by Unichem Laboratories Ltd. and labeled for Unichem Pharmaceuticals (USA), Inc. The label features barcodes and indicates the package contains 30 tablets (2 cards of 15 tablets each). Dimensions of the label are 123 mm by 75 mm, with additional panels.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 14

Label for Tadalafil Tablets USP 2.5 mg film-coated tablets, oral route, containing 30 tablets per container. The label includes dosage strength, manufacturer Unichem Laboratories Ltd. and Unichem Pharmaceuticals (USA), Inc., storage instructions, and a barcode with the NDC number 29300-286-13. It specifies the tablets should not be split and to take the entire dose.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 15

Label for Tadalafil Tablets USP 5 mg film-coated tablets by Unichem Pharmaceuticals (USA), Inc. The label specifies 30 tablets per container, with directions indicating tablets should not be split. Includes storage instructions and warnings to keep out of children's reach. Manufactured by Unichem Laboratories Ltd., India, and labeled for Unichem Pharmaceuticals (USA), Inc. Bar code and 2D matrix barcode area for GTIN, serial number, expiration, and lot information are also shown.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 16

Tadalafil Tablets USP 10 mg film-coated oral tablets label from Unichem Pharmaceuticals (USA), Inc. The label includes dosage instructions, storage conditions (20° to 25°C), and packaging details indicating 30 tablets per bottle. It features a barcode and states the product is Rx only. The label also shows manufacturing information for Unichem Laboratories Ltd., India, and Unichem Pharmaceuticals (USA), Inc.*

FDA Label Image

2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 17

Label for tadalafil tablets, USP 20 mg film-coated tablets, in a bottle of 30 tablets. The label includes dosage warnings, storage instructions, and manufacturer information: Unichem Laboratories Ltd. in India and Unichem Pharmaceuticals (USA), Inc. The label shows the NDC 29300-289-13 and features a 2D matrix barcode area for GTIN, serial number, expiration, and lot details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.